Zivo Bioscience Equity Warrants Exp 29 April 2026 ZIVOW:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.7499UNCH (UNCH)
Volume
500
52 week range
0.40 - 2.13
Loading...
  • Open0.7499
  • Day High0.7499
  • Day Low0.7499
  • Prev Close0.7499
  • 52 Week High2.13
  • 52 Week High Date07/13/21
  • 52 Week Low0.40
  • 52 Week Low Date04/28/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.7499
  • Day High0.7499
  • Day Low0.7499
  • Prev Close0.7499
  • 52 Week High2.13
  • 52 Week High Date07/13/21
  • 52 Week Low0.40
  • 52 Week Low Date04/28/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zivo Bioscience Equity Warrants Exp 29 April 2026

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Zivo Bioscience, Inc. is a research and development company. The Company is engaged in developing bioactive compounds derived from its algal culture, targeting human and animal diseases, such as poultry coccidiosis, bovine mastitis, human cholesterol, and canine osteoarthritis. Its algal biomass contains vitamin A, protein, iron, fatty acids, non-starch polysaccharides and other micronutrients. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health...
John Payne
Chairman of the Board, President, Chief Executive Office, Director
Keith Marchiando
Chief Financial Officer
Address
7 WEST SQUARE LAKE RD, Suite 100
Bloomfield Hills, MI
48302
United States